Licensing agreement deal values for innovator T-cell receptor (TCR) immunotherapy drugs for European biopharmaceutical companies increased by 325% (by $921 million) between 2023 to 2024 year-to-date ...

Cars are Andrew's jam, as is strawberry. After spending years as a regular ol' car fanatic, he started working his way through the echelons of the automotive industry, starting out as social-media ...

Medigene AG (Medigene, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies for the treatment of cancer, today ...

SEOUL, South Korea — Kumho Tire Co. Inc. has secured the naming rights for the TCR World Tour for touring cars, a global championship that overlaps with seven national and regional TCR series on four ...

The motorsport will be available on smart TVs, tablets, smartphones, and gaming consoles in more than 200 markets and territories DAZN has announced an agreement with touring car championship TCR ...

Chimeric antigen receptor (CAR) T-cell and T-cell receptor (TCR) T-cell therapies are promising treatments for a range of cancers, offering hope to patients whose cancers have become refractory to ...

LONDON — Sedan road-racing series in Europe running under Touring Car Championship (TCR) regulations are switching to race tires built by South Korea's Kumho Tire Co. Inc., according to the TCR's ...

EMERYVILLE, Calif.--(BUSINESS WIRE)--Eureka Therapeutics, Inc., a clinical stage biotechnology company developing novel T cell therapies to treat solid tumors, today announced that its Director of ...

Investors in the cell therapy industry are actively looking into solid tumours, autoimmune indications and novel engineering as the best place to allocate their money and resources. This, along with ...